ArticleOncology letters2020

Decreased biochemical progression in patients with castration-resistant prostate cancer using a novel mefenamic acid anti-inflammatory therapy: A randomized controlled trial.

José Guzman-Esquivel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.